Dana Farber Cancer Institute SC (1)
Dana Farber Cancer Institute SC (1)
Boston, Massachusetts, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, acute myeloid leukemia, adenocarcinoma, astrocytoma (excluding glioblastoma), bone marrow disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, glioblastoma, glioma, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-04-13 | NCT02381886 |